SCHEMBL24110970

SCHEMBL24110970

COc1ncccc1Nc1nc2ccc(Cl)cc2c(=O)n1-c1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAT2A P31153 1/20 0.47
TUBB4A P04350 1/20 0.46
TUBB P07437 1/20 0.46
TUBA3C P0DPH7 1/20 0.46
TUBA1B P68363 1/20 0.46
TUBA4A P68366 1/20 0.46
TUBB4B P68371 1/20 0.46
TUBB3 Q13509 1/20 0.46
TUBB2A Q13885 1/20 0.46
TUBB8 Q3ZCM7 1/20 0.46
TUBA3E Q6PEY2 1/20 0.46
TUBA1A Q71U36 1/20 0.46
TUBA1C Q9BQE3 1/20 0.46
TUBB6 Q9BUF5 1/20 0.46
TUBB2B Q9BVA1 1/20 0.46
TUBB1 Q9H4B7 1/20 0.46
PIK3CG P48736 4/20 0.44
PI4KA P42356 4/20 0.44
SMN1; SMN2 Q16637 1/20 0.43
PIK3CD O00329 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30103257 1.00 MAT2A (0.47) MAT2ATUBB4ATUBBTUBA3CTUBA1B
SCHEMBL24110859 0.87 TUBB4A (0.48) MAT2ATUBB4ATUBBTUBA3CTUBA1B
SCHEMBL24090096 0.83 TUBB4A (0.47) MAT2ATUBB4ATUBBTUBA3CTUBA1B
SCHEMBL23958175 0.82 MAPT (0.45) MAT2ATUBB4ATUBBTUBA3CTUBA1B
SCHEMBL24089999 0.82 MAPT (0.50) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL24110977 0.82 TUBB4A (0.54) MAT2ATUBB4ATUBBTUBA3CTUBA1B
SCHEMBL24110990 0.81 TUBB4A (0.49) MAT2ATUBB4ATUBBTUBA3CTUBA1B
SCHEMBL23064704 0.81 PDE10A (0.47) SMN1; SMN2TP53MAPT
SCHEMBL29623176 0.81 PDE10A (0.47) SMN1; SMN2TP53MAPT
SCHEMBL23064703 0.80 TUBB4A (0.44) TUBB4ATUBBTUBA3CTUBA1BTUBA4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115427399-A 2-heteroarylaminoquinazolinone derivatives 住友制药株式会社 2022-12-02 CN disclosed
US-20210387967-A1 2-HETEROARYL AMINOQUINAZOLINONE DERIVATIVE SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) 2021-12-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210387967-A1 2-HETEROARYL AMINOQUINAZOLINONE DERIVATIVE CRKL, CLIC4, CLIC1 MAT2A 4627/4885TUBB4A 3394/4885TUBB 4556/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.